D-(+)-2-(4-苯基哌啶基)环己醇盐酸盐 | 112709-60-1

• 物质功能分类: 医药中间体 - 杂环化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: D-(+)-2-(4-苯基哌啶基)环己醇盐酸盐
• 英文名称: (+)-Vesamicol
• 英文别名: (1S,2S)-2-(4-phenylpiperidin-1-yl)cyclohexanol；2-(4-Phenylpiperidino)cyclohexanol；(1S,2S)-2-(4-phenylpiperidin-1-yl)cyclohexan-1-ol
• CAS: 112709-60-1
• 化学式: C₁₇H₂₅NO
• 分子量: 259.392
• InChiKey: YSSBJODGIYRAMI-IRXDYDNUSA-N

物化性质

• 沸点：
  393.5±42.0 °C(Predicted)
• 密度：
  1.086±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于DMSO

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.65
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 安全说明：
  S36
• WGK Germany：
  3

制备方法与用途

D-(+)-2-(4-苯基哌啶基)环己醇盐酸盐是一种强效抑制剂，能够抑制乙酰胆碱向胆碱能神经末梢突触囊泡的转运。

反应信息

• 作为产物：
  描述：

  trans-2-piperidinocyclohexanol 在 sodium chlorite 、 lithium aluminium tetrahydride 、 三甲基氯硅烷 、 2,2,6,6-四甲基哌啶氧化物 作用下， 以 四氢呋喃 、 aq. phosphate buffer 、 叔丁醇 为溶剂， 反应 20.08h， 生成 D-(+)-2-(4-苯基哌啶基)环己醇盐酸盐
  参考文献：
  名称：

  哌啶向4-取代的和3,4-二取代的2-哌啶酮的无过渡金属的多重官能化。

  摘要：

  在不使用过渡金属催化剂和精细的导向基团的情况下，哌啶的远程和多重官能化是有机合成的主要挑战之一。本文报道了史无前例的两步方案，该方案能够使哌啶多功能化为4-取代的或反式的3,4-二取代的2-哌啶酮。首先，通过利用TEMPO反应性的对偶性（在氧化和热条件下在阳离子和持久自由基形式之间波动），开发了新颖的哌啶多C（sp3）-H氧化为α，β-不饱和2-哌啶酮的化合物。其次，通过使用三甲基甲硅烷基氯（TMSCl）作为路易斯酸，可以克服不饱和哌啶酮对共轭格氏试剂的固有的低反应性。随后，

  DOI：

  10.1002/chem.201905262

文献信息

• Compounds comprising 4-benzoylpiperidine as a Sigma-1-selective ligand
  申请人：Tu Zhude

  公开号：US20110311447A1

  公开（公告）日：2011-12-22

  Bipiperidinyl compounds and salts thereof are disclosed. The compounds include high affinity ligands for σ 1 receptors. Some compounds are also highly selective for σ 1 receptor compared to σ 2 receptor. Compounds can comprise radioisotopes, including 18 F or 11 C. Radiolabeled compounds can be used as probes for imaging distribution of σ 1 receptor in a subject such as a human using positron emission tomography (PET) scanning.

  双哌啶基化合物及其盐被披露。这些化合物包括对σ1受体具有高亲和力的配体。一些化合物相对于σ2受体也具有高选择性。化合物可以包含放射性同位素，包括18F或11C。放射标记的化合物可用作探针，用于通过正电子发射断层扫描（PET扫描）在受试者（如人类）中成像σ1受体的分布。
• Reactions of nitrogen nucleophiles with enantiopure cyclohexenyl electrophiles: a stereo- and regio- selective study
  作者：Derek R. Boyd、Narain D. Sharma、Tayeb Belhocine、John F. Malone、Stuart T. McGregor、Jordan Atchison、Peter A. B. McIntyre、Paul J. Stevenson

  DOI：10.1002/poc.3183

  日期：2013.12

  The reactions of enantiopure cyclohexene epoxides and trans‐1,2‐bromoacetates, derived from the corresponding substituted benzene cis‐dihydrodiol metabolites, with nitrogen nucleophiles, were examined and possible mechanisms proposed. An initial objective was the synthesis of new 1,2‐aminoalcohol enantiomers as potential chiral ligands and synthetic scaffolds for library generation. These apparently

  考察了对映体纯的环己烯环氧化物和反式1,2-溴乙酸酯的反应，它们衍生自相应的取代苯顺式-二氢二醇代谢物，并与氮亲核试剂反应，并提出了可能的机理。最初的目标是合成新的1,2-氨基醇对映异构体，作为潜在的手性配体和合成支架，以产生文库。这些看似简单的取代反应被证明比最初预期的要复杂，并且被发现涉及不同反应机理的组合。
• Direct access to the optically active VAChT inhibitor vesamicol and its analogues via the asymmetric aminolysis of meso-epoxides with secondary aliphatic amines
  作者：Arun Sharma、Jyoti Agarwal、Rama Krishna Peddinti

  DOI：10.1039/c6ob02479c

  日期：——

  biologically important vesamicol, benzovesamicol, and their derivatives was achieved via the desymmetrization of meso-epoxides with secondary aliphatic amines (4-phenylpiperidine derivatives) using a chiral [salenCo(III)-BF4] catalyst at room temperature. All products were obtained in good yield and with excellent optical induction.

  通过使用手性 [salenCo( III ) -BF 4 ] 催化剂在室温下使内消旋环氧化物与脂肪族仲胺（4-苯基哌啶衍生物）去对称化，首次实现了具有重要生物学意义的 vesamicol、benzovesamicol 及其衍生物的高度对映选择性合成。所有产品均以良好的收率和优异的光诱导获得。
• Production Method of Optically Active Cyclohexane Ether Compounds
  申请人：Machiya Koji

  公开号：US20090005576A1

  公开（公告）日：2009-01-01

  The present invention relates to an industrial synthetic method of an optically active cyclohexane ether compound (IIIa) or a salt thereof, which is useful as a pharmaceutical agent, and an intermediate useful for the production method of the present invention. The production method of the present invention is as shown below: wherein each symbol is as defined in the specification. According to the production method of the present invention, efficient and stable supply of an optically active cyclohexane ether compound (IIIa) in a high yield at a lower cost can be afforded. Therefore, an optically active cyclohexane ether compound (IIIa) extremely useful as a pharmaceutical agent can be provided by an industrially highly advantageous method.

  本发明涉及一种工业合成方法，用于制备一种光学活性的环己烷醚化合物（IIIa）或其盐，该化合物在制药上有用，并提供了一种用于本发明生产方法的中间体。本发明的生产方法如下所示：其中每个符号如规范中定义。根据本发明的生产方法，可以以较低成本高产率地提供一种光学活性的环己烷醚化合物（IIIa），从而提供了一种在工业上极具优势的方法，极其有用于制药的光学活性环己烷醚化合物（IIIa）。
• Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogs of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol)
  作者：Gary A. Rogers、Stanley M. Parsons、D. C. Anderson、Lena M. Nilsson、Ben A. Bahr、Wayne D. Kornreich、Rose Kaufman、Robert S. Jacobs、Bernard Kirtman

  DOI：10.1021/jm00126a013

  日期：1989.6

  Eighty-four analogues and derivatives of the acetylcholine-storage-blocking drug trans-2-(4-phenylpiperidino)-cyclohexanol (vesamicol) were synthesized, and their potencies were evaluated with the acetylcholine active-transport assay utilizing purified synaptic vesicles from Torpedo electric organ. The parent drug exhibits enantioselectivity, with (-)-vesamicol being 25-fold more potent than (+)-vesamicol. The atomic structure and absolute configuration of (+)-vesamicol were determined by X-ray crystallography. The absolute configuration of (-)-vesamicol is 1R,2R. Structure-activity evidence indicates that (-)-vesamicol does not act as an acetylcholine analogue. Alterations to all three rings can have large effects on potency. Unexpectedly, analogues locking the alcohol and ammonium groups trans-diequatorial or trans-diaxial both exhibit good potency. A potent benzovesamicol family has been discovered that is suitable for facile elaboration of the sort useful in affinity labeling and affinity chromatography applications. A good correlation was found between potencies as assessed by the acetylcholine transport assay and LD50 values in mouse.